Ari Brekkan, Ph.D.



  • Joined Pharmetheus in 2019, actively working in client projects.
  • Expertise includes pharmacometrics, especially models for biological medicinal products, and trial design in therapeutic areas such as immunology and haemophilia.
  • Experience as temporary Consultant at Pharmetheus where he worked with hands-on application of pharmacometric approaches to support drug development in various therapeutic areas.
  • M.Sc. in Drug Discovery and Development (2012) and Ph.D. in Pharmaceutical Science (2019) from Uppsala University, Sweden.
LinkedInGoogle Scholar

Pharmetheus affiliated publications

Investigating the Identifiability of One-Stage IVIVC Population Models for Extended-Release Dosage FormsSensitivity of Pegfilgrastim Pharmacokinetic and Pharmacodynamic Parameters to Product Differences in Similarity StudiesModel Based Support to Biosimilarity Assessment Planning – A Case Study of PegfilgrastimA Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim